A case report: Clozapine-induced leukopenia and neutropenia after mRNA COVID-19 vaccination.

Imai, Tomoyuki; Ochiai, Sho; Ishimaru, Takehiro; Daitoku, Hayato; Miyagawa, Yusuke; Fukuhara, Ryuji; Boku, Shuken; Takebayashi, Minoru

Imai, Tomoyuki; Ochiai, Sho; Ishimaru, Takehiro; Daitoku, Hayato; Miyagawa, Yusuke; Fukuhara, Ryuji; Boku, Shuken; Takebayashi, Minoru.

Afiliação

Imai T; Department of Neuropsychiatry, Kumamoto University Hospital, Kumamoto, Japan.
Ochiai S; Department of Neuropsychiatry, Kumamoto University Hospital, Kumamoto, Japan.
Ishimaru T; Comprehensive Clinical Education, Training and Development Center, Kumamoto University, Kumamoto, Japan.
Daitoku H; Minamata City General Hospital and Medical Center, Minamata, Japan.
Miyagawa Y; Department of Neuropsychiatry, Kumamoto University Hospital, Kumamoto, Japan.
Fukuhara R; Department of Neuropsychiatry, Kumamoto University Hospital, Kumamoto, Japan.
Boku S; Department of Neuropsychiatry, Faculty of Life Science, Kumamoto University, Kumamoto, Japan.
Takebayashi M; Department of Neuropsychiatry, Kumamoto University Hospital, Kumamoto, Japan.

Neuropsychopharmacol Rep ; 42(2): 238-240, 2022 06.

Article em En | MEDLINE | ID: mdl-35166466

Assuntos

Tratamento Farmacológico da COVID-19; COVID-19; Clozapina; Neutropenia; Esquizofrenia; Adulto; COVID-19/prevenção & controle; Vacinas contra COVID-19/efeitos adversos; Clozapina/efeitos adversos; Feminino; Humanos; Neutropenia/induzido quimicamente; RNA Mensageiro; Esquizofrenia/tratamento farmacológico; Vacinação

Palavras-chave

COVID-19 vaccine; clozapine; leukopenia; neutropenia; schizophrenia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Clozapina / COVID-19 / Tratamento Farmacológico da COVID-19 / Neutropenia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google